Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

Management of agitation and aggression associated with Alzheimer disease.

Ballard CG, Gauthier S, Cummings JL, Brodaty H, Grossberg GT, Robert P, Lyketsos CG.

Nat Rev Neurol. 2009 May;5(5):245-55. doi: 10.1038/nrneurol.2009.39. Review.

PMID:
19488082
2.

Management of agitation and aggression associated with Alzheimer's disease: controversies and possible solutions.

Ballard C, Corbett A, Chitramohan R, Aarsland D.

Curr Opin Psychiatry. 2009 Nov;22(6):532-40. doi: 10.1097/YCO.0b013e32833111f9. Review.

PMID:
19696673
3.

Agitation and aggression in people with Alzheimer's disease.

Ballard C, Corbett A.

Curr Opin Psychiatry. 2013 May;26(3):252-9. doi: 10.1097/YCO.0b013e32835f414b. Review.

PMID:
23528917
4.

Management of neuropsychiatric symptoms in people with dementia.

Ballard C, Corbett A.

CNS Drugs. 2010 Sep;24(9):729-39. doi: 10.2165/11319240-000000000-00000. Review.

PMID:
20806986
5.

Management of aggression, agitation, and psychosis in dementia: focus on atypical antipsychotics.

Aupperle P.

Am J Alzheimers Dis Other Demen. 2006 Mar-Apr;21(2):101-8. Review.

PMID:
16634465
6.

Progresses in treating agitation: a major clinical challenge in Alzheimer's disease.

Panza F, Solfrizzi V, Seripa D, Imbimbo BP, Santamato A, Lozupone M, Prete C, Greco A, Pilotto A, Logroscino G.

Expert Opin Pharmacother. 2015;16(17):2581-8. doi: 10.1517/14656566.2015.1092520. Epub 2015 Sep 21. Review.

PMID:
26389682
7.

Pharmacological Management of Agitation and Aggression in Alzheimer's Disease: A Review of Current and Novel Treatments.

Liu CS, Ruthirakuhan M, Chau SA, Herrmann N, Carvalho AF, Lanctôt KL.

Curr Alzheimer Res. 2016;13(10):1134-44. Review.

PMID:
27137221
8.

[Pharmacological treatment of behavioral symptoms in dementia patients].

Gabryelewicz T.

Przegl Lek. 2014;71(4):215-20. Review. Polish.

PMID:
25141581
9.

The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease.

Ballard C, Waite J.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD003476. Review.

PMID:
16437455
10.

Agitation and aggression in Alzheimer's disease: an update on pharmacological and psychosocial approaches to care.

Gallagher D, Herrmann N.

Neurodegener Dis Manag. 2015;5(1):75-83. doi: 10.2217/nmt.14.46. Review.

PMID:
25711456
11.

Optimal nonpharmacological management of agitation in Alzheimer's disease: challenges and solutions.

Millán-Calenti JC, Lorenzo-López L, Alonso-Búa B, de Labra C, González-Abraldes I, Maseda A.

Clin Interv Aging. 2016 Feb 22;11:175-84. doi: 10.2147/CIA.S69484. eCollection 2016. Review.

12.

Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy.

Salzman C, Jeste DV, Meyer RE, Cohen-Mansfield J, Cummings J, Grossberg GT, Jarvik L, Kraemer HC, Lebowitz BD, Maslow K, Pollock BG, Raskind M, Schultz SK, Wang P, Zito JM, Zubenko GS.

J Clin Psychiatry. 2008 Jun;69(6):889-98. Review.

13.

Atypical antipsychotics for the treatment of behavioral and psychological symptoms in dementia, with a particular focus on longer term outcomes and mortality.

Ballard C, Creese B, Corbett A, Aarsland D.

Expert Opin Drug Saf. 2011 Jan;10(1):35-43. doi: 10.1517/14740338.2010.506711. Epub 2010 Aug 5. Review.

PMID:
20684745
14.

An update on the advancements in the treatment of agitation in Alzheimer's disease.

Porsteinsson AP, Antonsdottir IM.

Expert Opin Pharmacother. 2017 Apr;18(6):611-620. doi: 10.1080/14656566.2017.1307340. Epub 2017 Mar 28. Review.

PMID:
28300462
15.

A systematic review of the clinical effectiveness and cost-effectiveness of sensory, psychological and behavioural interventions for managing agitation in older adults with dementia.

Livingston G, Kelly L, Lewis-Holmes E, Baio G, Morris S, Patel N, Omar RZ, Katona C, Cooper C.

Health Technol Assess. 2014 Jun;18(39):1-226, v-vi. doi: 10.3310/hta18390. Review.

16.

Antidepressants for agitation and psychosis in dementia.

Seitz DP, Adunuri N, Gill SS, Gruneir A, Herrmann N, Rochon P.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD008191. doi: 10.1002/14651858.CD008191.pub2. Review.

PMID:
21328305
17.

Psychotic symptoms, aggression and restlessness in dementia.

Ballard C, Gray A, Ayre G.

Rev Neurol (Paris). 1999;155 Suppl 4:S44-52. Review.

PMID:
10637938
18.

Risperidone in the management of agitation and aggression associated with psychiatric disorders.

De Deyn PP, Buitelaar J.

Eur Psychiatry. 2006 Jan;21(1):21-8. Epub 2006 Jan 18. Review.

PMID:
16414250
19.

Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.

Declercq T, Petrovic M, Azermai M, Vander Stichele R, De Sutter AI, van Driel ML, Christiaens T.

Cochrane Database Syst Rev. 2013 Mar 28;(3):CD007726. doi: 10.1002/14651858.CD007726.pub2. Review.

PMID:
23543555
20.

Advancements in the treatment of agitation in Alzheimer's disease.

Antonsdottir IM, Smith J, Keltz M, Porsteinsson AP.

Expert Opin Pharmacother. 2015;16(11):1649-56. doi: 10.1517/14656566.2015.1059422. Review.

PMID:
26159445

Supplemental Content

Support Center